A detailed history of Bank Of America Corp transactions in Entera Bio Ltd. stock. As of the latest transaction made, Bank Of America Corp holds 8,430 shares of ENTX stock, worth $14,583. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,430
Previous 3,000 181.0%
Holding current value
$14,583
Previous $5,000 220.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.48 - $2.14 $8,036 - $11,620
5,430 Added 181.0%
8,430 $16,000
Q2 2024

Aug 14, 2024

BUY
$1.73 - $2.98 $5,190 - $8,940
3,000 New
3,000 $5,000
Q1 2022

May 16, 2022

SELL
$1.91 - $3.23 $26,484 - $44,787
-13,866 Closed
0 $0
Q4 2021

Feb 08, 2022

SELL
$2.82 - $4.79 $6,505 - $11,050
-2,307 Reduced 14.26%
13,866 $39,000
Q3 2021

Nov 15, 2021

BUY
$4.43 - $6.29 $71,646 - $101,728
16,173 New
16,173 $76,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $49.8M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.